Other Information
+Added: During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, other than on May 1, 2023 , Medpace Investors, LLC (“MPI”) adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 500,000 shares of the Company’s common stock until September 14, 2024.
+Added: Troendle , Chief Executive Officer and Chairman of the Board of the Company , is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI.
+Added: Troendle may be deemed to indirectly beneficially own the securities of the Company held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The exhibits in the accompanying Exhibit Index preceding the signature page are filed or furnished as a part of this report and are incorporated herein by reference.
3 unchanged sentences
Exhibit Filing
−Removed: 10.1 Amendment No.
−Removed: 5 dated March 31, 2023 to Loan Documents
−Removed: 8-K 001-37856 10.1 3/31/2023
31.1 Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer
15 unchanged sentences
(Principal Financial Officer)
−Removed: April 25, 2023
+Added: July 25, 2023
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.